Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LTB4R | Q15722 | 3/20 | 0.57 |
| ▸ | RARB | P10826 | 1/20 | 0.51 |
| ▸ | HPGD | P15428 | 1/20 | 0.50 |
| ▸ | GAA | P10253 | 2/20 | 0.49 |
| ▸ | MAPT | P10636 | 2/20 | 0.47 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.46 |
| ▸ | MTNR1A | P48039 | 1/20 | 0.46 |
| ▸ | MTNR1B | P49286 | 1/20 | 0.46 |
| ▸ | TP53 | P04637 | 1/20 | 0.46 |
| ▸ | TSHR | P16473 | 1/20 | 0.46 |
| ▸ | LDHA | P00338 | 1/20 | 0.46 |
| ▸ | POLB | P06746 | 2/20 | 0.46 |
| ▸ | PLA2G4B | P0C869 | 1/20 | 0.45 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.45 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11652148 | 0.85 | LTB4R (0.56) | LTB4RRARBHPGDTDP1L3MBTL1 | |
| SCHEMBL8814018 | 0.82 | RARB (0.47) | LTB4RRARBGAAMAPK1TP53 | |
| SCHEMBL1803119 | 0.82 | RAB9A (0.55) | L3MBTL1 | |
| SCHEMBL6920635 | 0.80 | TDP1 (0.59) | LTB4RHPGDMAPTMAPK1MTNR1A | |
| SCHEMBL8487900 | 0.80 | MMP3 (0.47) | RARBHPGDMAPTMAPK1MTNR1A | |
| SCHEMBL8755014 | 0.78 | HPGD (0.49) | RARBHPGDGAAMAPTMTNR1A | |
| SCHEMBL9858456 | 0.77 | PPARG (0.50) | RARBHPGDGAAMAPTL3MBTL1 | |
| SCHEMBL15519724 | 0.77 | GRIK1 (0.55) | HPGD | |
| SCHEMBL14984020 | 0.77 | MAPT (0.60) | HPGDGAAMAPTMAPK1MTNR1A | |
| SCHEMBL30514009 | 0.77 | MAPT (0.60) | HPGDGAAMAPTMAPK1MTNR1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8410309-B2 | Phenoxy carboxylic acid compounds and compositions for delivering active agents | EMISPHERE TECHNOLOGIES, INC. (US) | 2013-04-02 | — | — | US | disclosed |
| US-7951971-B1 | Phenoxy carboxylic acid compounds and compositions for delivering active agents | EMISPHERE TECHNOLOGIES, INC. (US) | 2011-05-31 | — | — | US | disclosed |
| EP-1226104-B1 | PHENOXY CARBOXYLIC ACID COMPOUNDS AND COMPOSITIONS FOR DELIVERING ACTIVE AGENTS | EMISPHERE TECH INC (US) | 2009-04-08 | — | — | EP | disclosed |
| US-20060264513-A1 | PHENOXY CARBOXYLIC ACID COMPOUNDS AND COMPOSITIONS FOR DELIVERING ACTIVE AGENTS | EMISPHERE TECHNOLOGIES, INC. (US) | 2006-11-23 | — | — | US | disclosed |
| US-7129274-B1 | Phenoxy carboxylic acid compounds and compositions for delivering active agents | EMISPHERE TECHNOLOGIES INC. (US) | 2006-10-31 | — | — | US | disclosed |
| EP-1226104-A1 | PHENOXY CARBOXYLIC ACID COMPOUNDS AND COMPOSITIONS FOR DELIVERING ACTIVE AGENTS | Emisphere Technologies, Inc. (US) | 2002-07-31 | — | — | EP | disclosed |
| WO-2001032596-A1 | PHENOXY CARBOXYLIC ACID COMPOUNDS AND COMPOSITIONS FOR DELIVERING ACTIVE AGENTS | EMISPHERE TECHNOLOGIES, INC. (US) | 2001-05-10 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060264513-A1 | PHENOXY CARBOXYLIC ACID COMPOUNDS AND COMPOSITIONS FOR DELIVERING ACTIVE AGENTS | SLC46A1, H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16, PAICS | LTB4R 1836/4885RARB 526/4885HPGD 712/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.